Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
In the run-up to the Rio Olympic Games, ITV News speaks to four Olympic hopefuls in Team GB. Today we profile gymnast Claudia Fragapane.
The mother-in-law of Formula One billionaire Bernie Ecclestone has been kidnapped in Sau Paulo according to Brazilian media reports.
Four "siblings" of Dolly the sheep are in good health, raising hopes that the cloning process does not affect physical well-being.